Table 1.
Clinicopathological Data.
| IHC Cohort | TCGA Cohort | |||
|---|---|---|---|---|
| Parameters | Papillary Renal Cell Carcinoma N (%) | Clear Cell Renal Cell Carcinoma N (%) | Papillary Renal Cell Carcinoma N (%) | Clear Cell Renal Cell Carcinoma N (%) |
| Age (years) | ||||
| ≤65 | 16 (80) | 15 (60) | 170 (62) | 332 (66) |
| >65 | 4 (20) | 10 (40) | 104 (38) | 170 (34) |
| Gender | ||||
| Male | 13 (65) | 17 (68) | 208 (75) | 322 (64) |
| Female | 7 (35) | 8 (32) | 69 (25) | 180 (36) |
| pT Stage | ||||
| pT1 | 14 (70) | 13 (52) | 187 (68) | 248 (50) |
| pT2 | 3 (15) | 6 (24) | 32 (12) | 64 (13) |
| pT3 | 2 (10) | 6 (24) | 53 (19) | 177 (35) |
| pT4 | 1 (5) | 0 (0) | 2 (<1) | 11 (2) |
| Nuclear Grade | ||||
| 1–2 | 16 (80) | 17 (68) | N.A. | 223 (45) |
| 3–4 | 4 (20) | 8 (32) | N.A. | 271 (55) |
| Transplantation | ||||
| Post-transplant * | 4 (20) | 2 (8) | N.A. | N.A. |
| Non-transplant | 16 (80) | 23 (92) | N.A. | N.A. |
* Four patients received tacrolimus and two patients received cyclosporine as immunosuppressive therapy. Abbreviations: IHC, immunohistochemistry; N.A., not available; pT, pathological T stage; TCGA, The Cancer Genome Atlas.